Related Experiment Video
Updated: Mar 26, 2026
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
13.7K
Preventing infant mortality: Pharmacists' call to action
Journal of the American Pharmacists Association : Japha
|January 24, 2016
Summary
Pharmacists can significantly impact infant mortality rates through direct patient care and community linkages. Interventions span preconception to postpartum, addressing key infant death causes.
Area of Science:
- Public Health
- Pharmacy Practice
- Maternal and Child Health
Background:
- The United States infant mortality rate exceeds that of many industrialized nations.
- Infant mortality is influenced by various factors from conception through infancy.
Purpose of the Study:
- To identify and highlight the roles pharmacists can play in reducing infant mortality.
- To explore pharmacist interventions across the continuum of maternal and infant care.
Main Methods:
- Review of existing literature and practice guidelines.
- Identification of key intervention points for pharmacists.
- Analysis of pharmacist impact on leading causes of infant death.
Main Results:
- Pharmacists are accessible healthcare professionals with opportunities for intervention.
- Key intervention areas include family planning, substance use, folic acid, and medication management.
- Pharmacists can influence safe sleep, breastfeeding support, and vaccination rates.
Conclusions:
- Pharmacists can reduce infant mortality through direct patient care activities.
- Clinical-community linkages, research, and advocacy offer additional avenues for pharmacist influence.
- Targeted pharmacist interventions can contribute to lowering infant mortality rates.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.5K
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
10.2K
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
76
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
76
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
370
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
460
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460
01:29Drug Dosing: Infants and Children
733
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
697
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
697
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K